Digital Digitalisation of pharma in 2025: What’s holding firms back? The ability to operate with real-time data, integrated systems, and validated automation is now essential.
Views & Analysis In the healthcare and life sciences jungle – industry must a... As the digital revolution takes hold, life sciences companies must evolve or face the consequences.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
